In extreme-, high- and intermediate-risk patients with chronic kidney disease (CKD) undergoing transcatheter aortic valve replacement (TAVR) using balloon-expandable transcatheter heart valves (THV), progression to end-stage renal disease (ESRD) requiring hemodialysis (HD) is extremely rare follow TAVR.